Do patents shield disclosure or assure exclusivity when transacting technology?
نویسندگان
چکیده
Patents may assist trade in technology either by protecting buyers against the expropriation of the idea by third parties (the appropriation effect) or by enabling sellers to more frankly disclose the idea during the negotiation phase (the disclosure effect). We test for the presence of both these effects using quasiexperimental matching analysis on a novel dataset of 860 technology transaction negotiations. We identify the appropriation effect by comparing the probability of successful negotiations involving a granted patent with those involving a pending patent. Similarly, we identify the disclosure effect by comparing the probability of successful negotiations involving a pending patent with those involving no patent. We find evidence for the appropriation but not the disclosure effect: technology transaction negotiations involving a granted patent instead of a pending patent are 10 per cent more likely to be successfully completed (compared with an average completion rate of approximately 80 per cent). The authors have benefited from constructive comments from Sean Applegate, William Bird, Charlie Day, Rowan Gilmore, John Haisken-DeNew, Paul Jensen, John Kapeleris, Bruno Lambrecht, Di Nicol, Karen Sinclair, Russell Thomson, Andrew Toole and participants at the EPIP 2012 conference in Leuven, Belgium. Funding for this research comes from Intellectual Property Research Institute of Australia and the ARC LP0989343. Linkage partners were IP Australia, the Australian Institute for Commercialization, and Watermark Patent and Trademark Attorneys.
منابع مشابه
Monopolizing Clinical Trial Data: Implications and Trends
T he Agreement on Trade-Related Aspects of Intellectual Property Rights (the TRIPS Agreement, Box 1) has to a large extent harmonized standards for intellectual property rights, including patents. For many countries, the TRIPS standards were higher than their previous standards. For example, TRIPS obliges countries to allow patenting of pharmaceuticals and imposes a minimum duration of 20 years...
متن کاملSecondary patenting of branded pharmaceuticals: a case study of how patents on two HIV drugs could be extended for decades.
Pharmaceutical manufacturers rely on patents to protect their intellectual property and often seek to extend market exclusivity for their products to maximize their return on investment. One method is by obtaining patents on features other than the original active drug ingredient, including secondary patents on alternate formulations of the drug or on methods of administration. This article exa...
متن کاملRecommended response for human cloning patent applications.
The United States Patent and Trademark Office (“USPTO”) should not follow the recent decision of the European Union to invalidate patents pertaining to human cloning technology. First, human cloning inventions are clearly patentable in the United States; not only do these inventions meet the statutory requirements of proper subject matter and utility, but they are also not precluded from satisf...
متن کاملMaking Do in Making Drugs: Innovation Policy and Pharmaceutical Manufacturing
Despite increasing recalls, contamination events, and shortages, drug companies continue to rely on outdated manufacturing plants and processes. Drug manufacturing’s inefficiency and lack of innovation stand in stark contrast to drug discovery, which is the focus of a calibrated innovation policy that combines patents and FDA regulation. Pharmaceutical manufacturing lags far behind the innovati...
متن کامل-
The development and evolution of any system–person, organization–nation depends on how the system succeeds to bridge the gap between what the system knows and what the system does (with the knowledge). We call this the gap between knowing and doing or the knowing-doing gap. If the system does not do what it knows, it will lose out in competition with other systems, its relative performance in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2013